跳至主要内容
临床试验/IRCT20210925052576N1
IRCT20210925052576N1已完成2 期

Comparison of Sildenafil and Tadalafil in the treatment of benign prostatic hyperplasia

Islamic Azad University0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Male

入选标准

  • Diagnosed with Benign Prostatic Hyperplasia (BPH) with lower urinary tract symptoms(LUTS)
  • No prior history of other treatments in last month

排除标准

  • Unwilling to take part in the study
  • Concurrent treatment with Nitrates
  • History of cardiac diseases or hypotension
  • History of prostate surgery
  • History of Lumbar discopathy or prior herniated disc surgery
  • History of extensive pelvic or perineal surgeries
  • Being a known case of neurogenic bladder or presence of its symptoms
  • Having an active urinary tract infection (UTI)

研究者

相似试验